文献速递免疫规划传染病防控与疫情报告

中国福建省流行性腮腺炎疫情暴发特征调查

Investigating the characteristics of mumps outbreaks in Fujian Province, China.
PubMed 文献 · Vaccine · 2024-10-04

该研究分析2017至2022年福建省国家法定传染病报告系统报告的15,294例流行性腮腺炎病例,年发病率3.2/10万至8.0/10万。9至15岁组出现20起暴发共710例,均发生于2017至2019年且均在学校;仅27.6%病例至少接种1剂MuCV,其中94.9%在接种5年以上后发病。2019年后暴发急剧减少,作者建议密切监测年轻成人新暴发并可能启动该年龄组新接种策略。

要点

  • 2017至2019年9至15岁组报告20起流行性腮腺炎暴发共710例,均发生在学校。
  • 暴发中仅27.6%病例至少接种1剂MuCV,其中94.9%在接种5年以上后发病。
  • 2019年后暴发急剧减少,作者建议密切监测年轻成人新暴发并可能启动该年龄组新接种策略。

核心结论

  • 2017至2019年年轻成人中观察到的流行性腮腺炎暴发导致发病高峰,提示与疫苗接种覆盖率不理想及接种后间隔延长存在潜在关联。
  • 由于2020年以来这些发病高峰消失,作者建议密切监测年轻成人中的新暴发,并可能为此年龄组启动新的疫苗接种策略。

研究设计与样本

  • 研究基于中国国家法定传染病报告系统(NNCDRS)报告的流行性腮腺炎病例,对2017至2022年5年观察期内的病例按年度和年龄进行分析以检测疾病传播的同质性。
  • 若出现特定年龄高峰,则通过分析以暴发形式呈现的流行性腮腺炎病例的群体特征进行调查,包括人口学(年龄和性别)、临床症状、地点和时间识别及疫苗接种状态。

主要发现

  • 观察期内报告流行性腮腺炎病例总数为15,294例,年发病率为3.2/10万至8.0/10万。
  • 9至15岁较大年龄组按年度和年龄呈现20起暴发共710例,均发生于2017至2019年,此后该年龄组暴发消失。
  • 所有暴发均发生在学校环境,中位年龄13岁(范围6至19岁),腮腺肿大见于82.7%病例。
  • 暴发中位持续时间为28天,范围14至74天。
  • 仅27.6%病例至少接种1剂MuCV疫苗,其中94.9%在接种疫苗5年以上后发生流行性腮腺炎。

临床怎么用

  • 作者建议密切监测年轻成人中的新暴发,并可能为此年龄组启动新的疫苗接种策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Identifying the specifics and potential causes of mumps outbreaks in the Fujian Province during the period of 2017 to 2022. METHODS: Mumps cases reported by the National Notifiable Communicable Disease Report System (NNCDRS) in China during the observation period of the 5 years were investigated annually and by age to detect homogeneity of the spread of the disease over time. If specific age-peaks may appear, we investigated those figures by analysing group characteristics in mumps cases presented as outbreaks. Those characteristics include demography (age and sex), clinical symptoms, place and time identification, and vaccination status. Regarding the latter, it was hypothesized that cases manifesting an outbreaks and appearing in young adults should have a low vaccination coverage, and a long-lasting period since they received their vaccine. RESULTS: The total number of mumps cases reported during the observation period was 15,294, leading to incidence rates ranging from 3.2/100,000 to 8.0/100,000 per year. In the older age-group the disease spread by year and age (9 to 15y old) manifested 20 outbreaks accounting for 710 cases, all happening during 2017 to 2019. Thereafter those outbreaks disappeared in that age-group. The group characteristics specified that all the outbreaks happened in school settings, with a median age of 13y (range 6 to 19y). Parotid gland enlargement was observed in 82.7 %. The median duration of the outbreaks was 28 days, varying from 14 to 74 days. Only 27.6 % of the cases received at least one dose of the MuCV vaccine, and among these vaccinated individuals, 94.9 % developed mumps more than 5 years after vaccination. The dramatic reduction in outbreaks after 2019 could be explained by the public health measures taken during the COVID period and/or the new vaccination policy implemented in 2008 (free vaccination, 1 dose) and 2020 (2 doses) of young children causing therefore a lower rate of circulation of the virus. CONCLUSION: Mumps outbreaks observed in young adults during 2017-2019 causing a disease peak, indicated a potential link to unsatisfactory vaccination coverage with prolonged interval since receiving the vaccine. As those disease peaks disappeared since 2020, close monitoring for new outbreaks in young adults is recommended that may initiate a new vaccination strategy for that age-group.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Wu R, Chen Z, Yang X, et al. Investigating the characteristics of mumps outbreaks in Fujian Province, China. Vaccine. 2024. PMID: 39368125. doi:10.1016/j.vaccine.2024.126415

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。